Related Experiment Video

Updated: Nov 17, 2025

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

21.8K

'Hit and run' therapy averts macular degeneration

Felix Bubeck1,2, Dirk Grimm3,4,5

  • 1Department of Infectious Diseases/Virology, Medical Faculty, University of Heidelberg, Heidelberg, Germany.

Nature Biomedical Engineering
|February 13, 2021
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

10.5K
Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies
06:16

Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies

Published on: July 28, 2023

2.9K

Related Experiment Videos

Last Updated: Nov 17, 2025

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

21.8K
Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

10.5K
Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies
06:16

Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies

Published on: July 28, 2023

2.9K

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

822
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
822
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

950
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
950

Articles linked to this work by shared authors, journal, and citation graph.

Distinct YY dinucleotide periodicity in adeno-associated virus DNA.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Regulation of the Balance between Concentric and Eccentric Cardiac Hypertrophy by a CDC14A-KMT5A Signaling Pathway.

bioRxiv : the preprint server for biology·2026

Metagenomic Reconstruction of Adeno-Associated Virus Genomes.

Human gene therapy·2026

Sarcomeric remodelling in human heart failure unraveled by single molecule long read sequencing.

EMBO molecular medicine·2026

A versatile anti-CRISPR platform for opto- and chemogenetic control of CRISPR-Cas9 and Cas12 across a wide range of orthologs.

Nucleic acids research·2025

Clinically translatable mitochondrial gene therapy in muscle using tandem mtZFN architecture.

EMBO molecular medicine·2025

Causal graph neural networks for healthcare.

Nature biomedical engineering·2026

Engineered lipid nanoparticles for in vivo and durable editing of haematopoietic stem cells within humanized mice.

Nature biomedical engineering·2026

XunZi, an AI biologist, reveals disease-modifying targets.

Nature biomedical engineering·2026

Sulfated polysaccharides target RANK Lys97 to inhibit osteoclast differentiation and reverse osteoporosis.

Nature biomedical engineering·2026

In vivo CRISPR base editing for treatment of Huntington's disease.

Nature biomedical engineering·2026

Sequencing-free spatial profiling of post-transcriptional regulation in fresh tissues using nanoneedle arrays.

Nature biomedical engineering·2026

The Association of Uveitis with Prior Ocular Surgeries: A Within-Person Matched Case-Control Study.

Ocular immunology and inflammation·2026

Visual prodrome and syncope as atypical manifestations of severe triple-vessel coronary artery disease leading to motor vehicle collision: a case report.

European heart journal. Case reports·2026

Neuro-opthalmic Conditions Misdiagnosed as Glaucoma: A Retrospective Study of Cases and Contributing Factors in a Developing Setting.

Journal of current glaucoma practice·2026

Clinical Complications and Comorbidities Associated with Secondary Glaucoma: A Structured Literature Review.

Journal of current glaucoma practice·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us